Skip to main content
. 2023 Nov 13;14:1212813. doi: 10.3389/fphar.2023.1212813

TABLE 4.

Types, names and trial attribution of drugs.

Types Drug names Trial number
PD-1
Toripalimab 25
PD-1 inhibitor 14
Camrelizumab 13
Pembrolizumab 13
Sintilimab 9
Tislelizumab 9
Nivolumab 7
Penpulimab 3
Spartalizumab 2
Serplulimab 1
PD-L1
Avelumab 3
Atezolizumab 2
Durvalumab 2
SHR-1701 2
Envafolimab 1
INCB099280 1
INCB099318 1
TBQ2450 1
TQB2858 1
PD-1/CTLA-4
Cadonilimab 2